Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola,
Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment? | ONS Voice
HE4 & CA125 serum levels in patients with EOC according to tumor stage... | Download Table
Tumour marker HE4 and CA125 in ovarian cancer - Sullivan ...
Calibrators for HE4 and HER2 Tumor Marker Assays | Clinical Lab Products
Reference ranges of HE4 in different populations | Download Table
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer - Gynecologic Oncology
IJMS | Free Full-Text | Expression and Diagnostic Value of HE4 in Pancreatic Adenocarcinoma | HTML
Control FD HE4, HER2 Tumor Markers, Laboratory Quality Control, Daily Quality Control Material | AUDIT MicroControls, Inc.
HE4 (Human Epididymis Protein 4),Tellgen Corporation_specification/price/image_Bio-Equip in China
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
Tumor Marker Control | Fujirebio
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
HE4: A Novel Serum Biomarker for Monitoring and Managing Epithelial Ovarian Cancer
The biomarker diagnostic clarity
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125
HE4 in ovarian and uterine cancer » Professor Andreas Obermair
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
![PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ad5e941b87910036df87050d122d3db985bbadce/2-TableI-1.png "PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar")
PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
HE4 reference range in healthy populations according to age or... | Download Table
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
